Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

China

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian

Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian

Zhongshan Hospital Fudan University, Shanghai, Shanghai Municipality

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang